GABA synapses, depression, and antidepressant drugs.

[1]  K. Lloyd,et al.  Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. , 1985, The Journal of pharmacology and experimental therapeutics.

[2]  H. Emrich,et al.  The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. , 1985, Journal of affective disorders.

[3]  P. Suzdak,et al.  Parallel changes in the sensitivity of γ-aminobutyric acid and noradrenergic receptors following chronic administration of antidepressant and GABAergic drugs A possible role in affective disorders , 1985, Neuropharmacology.

[4]  Hill Dr.  GABAB receptor modulation of adenylate cyclase activity in rat brain slices. , 1985 .

[5]  B. Shaywitz,et al.  CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. , 1984, The American journal of psychiatry.

[6]  R. Quirion,et al.  Antidepressant--anxiolytic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants. , 1984, European journal of pharmacology.

[7]  K. Lloyd,et al.  Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. , 1984, Life sciences.

[8]  Leonard Be.  The olfactory bulbectomized rat as a model of depression. , 1984 .

[9]  P. Willner.  The ability of antidepressant drugs to desensitize beta-receptors is inversely correlated with their clinical potency. , 1984, Journal of affective disorders.

[10]  R. Duman,et al.  GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex , 1984, Brain Research.

[11]  J. Vetulani,et al.  Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments. , 1984, Polish journal of pharmacology and pharmacy.

[12]  B. Scatton,et al.  The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials , 1983, Pharmacology Biochemistry and Behavior.

[13]  R. Duman,et al.  Biochemical identification of multiple GABAB binding sites: association with noradrenergic terminals in rat forebrain , 1983, Brain Research.

[14]  H. Emrich,et al.  Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary Report , 1983, Pharmacology Biochemistry and Behavior.

[15]  J. Korf,et al.  Desmethylimipramine Enhances the Release of Endogenous GABA and Other Neuro trans mitter Amino Acids from the Rat Thalamus , 1983, Journal of neurochemistry.

[16]  J. Nurnberger,et al.  Plasma and CSF Gaba in Affective Illness , 1982, British Journal of Psychiatry.

[17]  S. Otsuki,et al.  Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. , 1982, Biological psychiatry.

[18]  F. Petty,et al.  Additivity of neurochemical changes in learned helplessness and imipramine. , 1982, Behavioral and neural biology.

[19]  A. Green.  Antidepressants: neurochemical, behavioural and clinical perspectives S.J. Enna J.B. , 1982, Neuroscience.

[20]  B. Scatton,et al.  gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas. , 1982, The Journal of pharmacology and experimental therapeutics.

[21]  R. Tissot,et al.  gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. , 1982, The Journal of pharmacology and experimental therapeutics.

[22]  F. Petty,et al.  Specificity of the learned helplessness model of depression , 1982, Pharmacology Biochemistry and Behavior.

[23]  D. Condorelli,et al.  Effects of some typical and atypical antidepressants on GAD activity in various brain regions. , 1982, L'Encephale.

[24]  A J Rush,et al.  Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression. , 1981, Archives of general psychiatry.

[25]  F. Petty,et al.  Plasma GABA in affective illness. A preliminary investigation. , 1981, Journal of Affective Disorders.

[26]  P. Worms,et al.  Reversal of the antiaversive and anticonvulsant actions of diazepam, but not of progabide, by a selective antagonist of benzodiazepine receptors. , 1981, European journal of pharmacology.

[27]  R. Gerner.  Dr. Gerner Replies , 1981 .

[28]  R. Gerner,et al.  CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. , 1981, The American journal of psychiatry.

[29]  N. Bowery,et al.  3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain , 1981, Nature.

[30]  F. Goodwin,et al.  Cerebrospinal fluid GABA in normals and patients with affective disorders , 1980, Brain Research Bulletin.

[31]  K. Lloyd,et al.  Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats , 1980, Pharmacology Biochemistry and Behavior.

[32]  Z. Koles,et al.  EEG Studies in Depression, Mania and Normals: Evidence for Partial Shifts of Laterality in the Affective Psychoses , 1980 .

[33]  R. Roth,et al.  GABA levels in CSF of patients with psychiatric disorders. , 1980, The American journal of psychiatry.

[34]  R. Ruff,et al.  Catatonia with frontal lobe atrophy. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[35]  G. Siggins,et al.  Chronic treatment with lithium or desipramine alters discharge frequency and norepinephrine responsiveness of cerebellar Purkinje cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Aghajanian,et al.  Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. , 1978, Science.

[37]  Hollister Le.  Tricyclic antidepressants (second of two parts). , 1978 .

[38]  R. Olsen,et al.  Effects of drugs on γ-aminobutyric acid receptors, uptake, release and synthesis in vitro , 1978, Brain Research.

[39]  W. Clark,et al.  Principles of psychopharmacology , 1978 .

[40]  E. Riva,et al.  BRAIN DISTRIBUTION AND PHARMACOKINETICS OF PSYCHOTROPIC DRUGS: DESIPRAMINE , 1978 .

[41]  A. Delini-Stula,et al.  Influence of baclofen and GABA-minetic agents on spontaneous and olfactory-bulb-ablation-induced muricidal behaviour in the rat. , 1978, Arzneimittel-Forschung.

[42]  F. Sulser.  Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders , 1978, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[43]  Robert H. Perry,et al.  Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue , 1977, Journal of the Neurological Sciences.

[44]  G. Tunnicliff.  Centrally-acting drugs and the formation of brain γ-aminobutyric acid , 1976 .

[45]  C. Winek,et al.  Tabulation of therapeutic, toxic, and lethal concentrations of drugs and chemicals in blood. , 1976, Clinical chemistry.

[46]  H. Lal,et al.  Effect of desipramine and pargyline on brain gamma-aminobutyric acid. , 1975, Biochemical pharmacology.

[47]  S. R. Snodgrass,et al.  GABA TRANSPORT BY NERVE ENDING FRACTIONS OF CAT BRAIN 1 , 1973, Journal of neurochemistry.

[48]  M. Neal,et al.  Effect of centrally acting drugs on the uptake of γ‐aminobutyric acid (GABA) by slices of rat cerebral cortex , 1973, British journal of pharmacology.

[49]  K. Elliott,et al.  FACTORS THAT AFFECT THE BINDING AND UPTAKE OF GABA BY BRAIN TISSUE 1 , 1971, Journal of neurochemistry.

[50]  R. Ruiz.  D-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO THE STANDARD DRUGS: A STUDY OF 116 CASES. , 1964, Diseases of the chest.

[51]  W. C. Walker,et al.  Cycloserine in the treatment of pulmonary tuberculosis; a report on toxicity. , 1957, Tubercle.

[52]  W. C. Lewis,et al.  Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis. , 1957, Diseases of the chest.